<DOC>
	<DOCNO>NCT00456625</DOCNO>
	<brief_summary>The current study evaluate immunological memory hepatitis B antigen subject receive primary neonatal vaccination hepatitis B vaccine ( Engerixâ„¢-B ) , 20 year ago primary study anti-HBs antibody concentration &lt; pre-defined cut-off value previous long-term time point . All participate subject receive challenge dose hepatitis B vaccine . Subjects age approximately 20-21 year time study . No new subject recruit long-term follow-up study . Blood sample do one month administration challenge dose . The Protocol Posting update order comply FDA Amendment Act , Sep 2007 .</brief_summary>
	<brief_title>Immune Response Hepatitis B Vaccine Challenge Dose Subjects Who Received Primary Neonatal Hepatitis B Vaccine .</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Subjects investigator believe comply requirement protocol enrol study . A male female adult receive complete neonatal primary vaccination course hepatitis B vaccine primary study approximately 20 year earlier . Documented level antiHBs antibody concentration &lt; specify concentration previous longterm time point serological result available subject . Written inform consent obtain subject . Healthy subject establish medical history clinical examination enter study . If subject female , must nonchildbearing potential childbearing potential , must practice adequate contraception 30 day prior vaccination , negative pregnancy test continue precaution 2 month completion hepatitis B challenge dose . Chronic administration ( defined 14 day ) immunosuppressant immunemodifying drug within six month prior hepatitis B vaccine challenge dose . Administration vaccine foreseen study protocol study period . Administration immunoglobulins and/or blood product study period . Drug and/or alcohol abuse .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Hepatitis B vaccine</keyword>
	<keyword>Challenge dose</keyword>
</DOC>